Pulmonary prognosis in cystic fibrosis patients with liver disease

Journal of Pediatrics

Volumn 149, Issue 1, 2006, Pages 144-

  Slieker, Martijn G ^a   van der Doef, Hubert P J ^a   Deckers Kocken, Judith M ^a   van der Ent, Cornelis K ^a   Houwen, Roderick H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIRTH; CYSTIC FIBROSIS; DISEASE ASSOCIATION; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; SPLENOMEGALY; STATISTICAL SIGNIFICANCE;

CASE-CONTROL STUDIES; CHILD; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HUMANS; LIVER DISEASES; SPLENOMEGALY; VITAL CAPACITY;

EID: 33745957843     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.12.018     Document Type: Letter

References (5)

1. Corbett K., Kelleher S., Rowland M., Daly L., Drumm B., Canny G., et al. Cystic fibrosis-associated liver disease. a population-based study. J Pediatr 145 (2004) 327-332
2. Colombo C., Battezzati P.M., Crosignani A., Morabito A., Costantini D., Padoan R., et al. Liver disease in cystic fibrosis. a prospective study on incidence, risk factors, and outcome. Hepatology 36 (2002) 1374-1382
3. Lamireau T., Monnereau S., Martin S., Marcotte J.E., Winnock M., and Alvarez F. Epidemiology of liver disease in cystic fibrosis. a longitudinal study. J Hepatol 41 (2004) 920-925
4. Slieker M.G., Deckers-Kocken J.M., Uiterwaal C.S.P.M., van der Ent C.K., and Houwen R.H.J. Risk factors for the development of cystic fibrosis related liver disease. Hepatology 38 (2003) 775-776
5. Angulo P. Use of ursodeoxycholic acid in patients with liver disease. Curr Gastroenterol Rep 4 (2002) 37-44